{"id":1377,"date":"2014-02-12T10:35:14","date_gmt":"2014-02-12T10:35:14","guid":{"rendered":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/?p=1377"},"modified":"2014-02-13T20:04:06","modified_gmt":"2014-02-13T20:04:06","slug":"nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom","status":"publish","type":"post","link":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\/","title":{"rendered":"Nochmal: Monitoring der Thrombozytenhemmung nach akutem Koronarsyndrom?"},"content":{"rendered":"<p>AMB\u00a02011,\u00a045, 84 &nbsp; Nochmal: Monitoring der Thrombozytenhemmung nach akutem Koronarsyndrom? &nbsp; Zum Thema Therapiemonitoring der Thrombozytenfunktion nach akutem Koronarsyndrom (AKS) haben wir ausf\u00fchrlich im Mai dieses Jahres berichtet (1). Im JAMA erschien k\u00fcrzlich aus einem Studienzentrum in Florenz eine weitere Studie, in die zwischen 2005 und 2009 insgesamt 1789 Patienten mit AKS (mittleres Alter ca. [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>AMB\u00a02011,\u00a045, 84 &nbsp; Nochmal: Monitoring der Thrombozytenhemmung nach akutem Koronarsyndrom? &nbsp; Zum Thema Therapiemonitoring der Thrombozytenfunktion nach akutem Koronarsyndrom (AKS) haben wir ausf\u00fchrlich im Mai dieses Jahres berichtet (1). Im JAMA erschien k\u00fcrzlich aus einem Studienzentrum in Florenz eine weitere Studie, in die zwischen 2005 und 2009 insgesamt 1789 Patienten mit AKS (mittleres Alter ca. [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","footnotes":""},"categories":[199,607],"tags":[128,75,76,643,129,139,78,79,74,85,106,146,644],"class_list":["post-1377","post","type-post","status-publish","format-standard","hentry","category-jahr-2011-band-45","category-monat-11-jahr-2011-band-45","tag-acetylsalicylsaeure","tag-akutes-koronarsyndrom","tag-angina-pectoris","tag-aspirin-resistenz","tag-azetylsalizylsaeure","tag-clopidogrel","tag-herzinfarkt","tag-koronare-herzkrankheit","tag-myokardinfarkt","tag-prasugrel","tag-thrombozytenaggregationshemmer","tag-ticagrelor","tag-ticlopidin"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nochmal: Monitoring der Thrombozytenhemmung nach akutem Koronarsyndrom?<\/title>\n<meta name=\"description\" content=\"Monitoring der Thrombozytenhemmung nach akutem Koronarsyndrom - UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken --&gt;\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nochmal: Monitoring der Thrombozytenhemmung nach akutem Koronarsyndrom?\" \/>\n<meta property=\"og:description\" content=\"Monitoring der Thrombozytenhemmung nach akutem Koronarsyndrom - UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken --&gt;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\/\" \/>\n<meta property=\"og:site_name\" content=\"Der Arzneimittelbrief\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/derarzneimittelbrief.de\" \/>\n<meta property=\"article:published_time\" content=\"2014-02-12T10:35:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2014-02-13T20:04:06+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.der-arzneimittelbrief.de\/_images\/link.jpeg\" \/>\n<meta name=\"author\" content=\"henk-amb\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"henk-amb\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"4\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\\\/\"},\"author\":{\"name\":\"henk-amb\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/2e7981c97826a4941311e607c145d937\"},\"headline\":\"Nochmal: Monitoring der Thrombozytenhemmung nach akutem Koronarsyndrom?\",\"datePublished\":\"2014-02-12T10:35:14+00:00\",\"dateModified\":\"2014-02-13T20:04:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\\\/\"},\"wordCount\":817,\"image\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/www.der-arzneimittelbrief.de\\\/_images\\\/link.jpeg\",\"keywords\":[\"Acetylsalicyls\u00e4ure\",\"Akutes Koronarsyndrom\",\"Angina pectoris\",\"Aspirin-Resistenz\",\"Azetylsalizyls\u00e4ure\",\"Clopidogrel\",\"Herzinfarkt\",\"Koronare Herzkrankheit\",\"Myokardinfarkt\",\"Prasugrel\",\"Thrombozytenaggregationshemmer\",\"Ticagrelor\",\"Ticlopidin\"],\"articleSection\":[\"Jahr 2011 Band 45\",\"Monat 11\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\\\/\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\\\/\",\"name\":\"Nochmal: Monitoring der Thrombozytenhemmung nach akutem Koronarsyndrom?\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/www.der-arzneimittelbrief.de\\\/_images\\\/link.jpeg\",\"datePublished\":\"2014-02-12T10:35:14+00:00\",\"dateModified\":\"2014-02-13T20:04:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/2e7981c97826a4941311e607c145d937\"},\"description\":\"Monitoring der Thrombozytenhemmung nach akutem Koronarsyndrom - UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken -->\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\\\/#primaryimage\",\"url\":\"http:\\\/\\\/www.der-arzneimittelbrief.de\\\/_images\\\/link.jpeg\",\"contentUrl\":\"http:\\\/\\\/www.der-arzneimittelbrief.de\\\/_images\\\/link.jpeg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Start\",\"item\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nochmal: Monitoring der Thrombozytenhemmung nach akutem Koronarsyndrom?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\",\"name\":\"Der Arzneimittelbrief\",\"description\":\"Unabh\u00e4ngige Arzneimittelinformationen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/2e7981c97826a4941311e607c145d937\",\"name\":\"henk-amb\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/314c85e3c5c37749a415d1df0e5fe7642768dd0d2f48f8a4fea70eae9b7499fc?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/314c85e3c5c37749a415d1df0e5fe7642768dd0d2f48f8a4fea70eae9b7499fc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/314c85e3c5c37749a415d1df0e5fe7642768dd0d2f48f8a4fea70eae9b7499fc?s=96&d=mm&r=g\",\"caption\":\"henk-amb\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nochmal: Monitoring der Thrombozytenhemmung nach akutem Koronarsyndrom?","description":"Monitoring der Thrombozytenhemmung nach akutem Koronarsyndrom - UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken -->","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\/","og_locale":"de_DE","og_type":"article","og_title":"Nochmal: Monitoring der Thrombozytenhemmung nach akutem Koronarsyndrom?","og_description":"Monitoring der Thrombozytenhemmung nach akutem Koronarsyndrom - UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken -->","og_url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\/","og_site_name":"Der Arzneimittelbrief","article_publisher":"http:\/\/www.facebook.com\/derarzneimittelbrief.de","article_published_time":"2014-02-12T10:35:14+00:00","article_modified_time":"2014-02-13T20:04:06+00:00","og_image":[{"url":"http:\/\/www.der-arzneimittelbrief.de\/_images\/link.jpeg","type":"","width":"","height":""}],"author":"henk-amb","twitter_misc":{"Verfasst von":"henk-amb","Gesch\u00e4tzte Lesezeit":"4\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\/#article","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\/"},"author":{"name":"henk-amb","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/2e7981c97826a4941311e607c145d937"},"headline":"Nochmal: Monitoring der Thrombozytenhemmung nach akutem Koronarsyndrom?","datePublished":"2014-02-12T10:35:14+00:00","dateModified":"2014-02-13T20:04:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\/"},"wordCount":817,"image":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\/#primaryimage"},"thumbnailUrl":"http:\/\/www.der-arzneimittelbrief.de\/_images\/link.jpeg","keywords":["Acetylsalicyls\u00e4ure","Akutes Koronarsyndrom","Angina pectoris","Aspirin-Resistenz","Azetylsalizyls\u00e4ure","Clopidogrel","Herzinfarkt","Koronare Herzkrankheit","Myokardinfarkt","Prasugrel","Thrombozytenaggregationshemmer","Ticagrelor","Ticlopidin"],"articleSection":["Jahr 2011 Band 45","Monat 11"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\/","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\/","name":"Nochmal: Monitoring der Thrombozytenhemmung nach akutem Koronarsyndrom?","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\/#primaryimage"},"image":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\/#primaryimage"},"thumbnailUrl":"http:\/\/www.der-arzneimittelbrief.de\/_images\/link.jpeg","datePublished":"2014-02-12T10:35:14+00:00","dateModified":"2014-02-13T20:04:06+00:00","author":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/2e7981c97826a4941311e607c145d937"},"description":"Monitoring der Thrombozytenhemmung nach akutem Koronarsyndrom - UNABH\u00c4NGIGE ARZNEIMITTELINFORMATIONEN hier klicken -->","breadcrumb":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\/#primaryimage","url":"http:\/\/www.der-arzneimittelbrief.de\/_images\/link.jpeg","contentUrl":"http:\/\/www.der-arzneimittelbrief.de\/_images\/link.jpeg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/nochmal-monitoring-der-thrombozytenhemmung-nach-akutem-koronarsyndrom\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Start","item":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/"},{"@type":"ListItem","position":2,"name":"Nochmal: Monitoring der Thrombozytenhemmung nach akutem Koronarsyndrom?"}]},{"@type":"WebSite","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/","name":"Der Arzneimittelbrief","description":"Unabh\u00e4ngige Arzneimittelinformationen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/2e7981c97826a4941311e607c145d937","name":"henk-amb","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/314c85e3c5c37749a415d1df0e5fe7642768dd0d2f48f8a4fea70eae9b7499fc?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/314c85e3c5c37749a415d1df0e5fe7642768dd0d2f48f8a4fea70eae9b7499fc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/314c85e3c5c37749a415d1df0e5fe7642768dd0d2f48f8a4fea70eae9b7499fc?s=96&d=mm&r=g","caption":"henk-amb"}}]}},"_links":{"self":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/1377","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/comments?post=1377"}],"version-history":[{"count":1,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/1377\/revisions"}],"predecessor-version":[{"id":1378,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/1377\/revisions\/1378"}],"wp:attachment":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/media?parent=1377"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/categories?post=1377"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/tags?post=1377"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}